Antithrombin effect of polyphenol-rich extracts from black chokeberry and grape seeds

Phytotherapy Research

Volumn 27, Issue 1, 2013, Pages 71-76

  Bijak, Michał ^a   Saluk, Joanna ^a   Ponczek, Michał Błazej ^a   Nowak, Paweł ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

antithrombin; chokeberry; grape seeds; polyphenols; thrombin; thrombin inhibition

Indexed keywords

BLACK CHOKEBERRY EXTRACT; CATECHIN; CHLOROGENIC ACID; CYANIDIN; CYANIDIN 3 GLUCOSIDE; EPICATECHIN; FIBRINOGEN; GALLIC ACID; GRAPE SEED EXTRACT; PLANT EXTRACT; POLYPHENOL; PROCYANIDIN; QUERCETIN; THROMBIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARONIA MELANOCARPA; ARTICLE; BLACK CHOKEBERRY; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE CONTROL; ENZYME INHIBITION; FIBRIN FORMATION; GRAPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; PHYTOCHEMISTRY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN POLYMERIZATION; ROSACEAE; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOSIS;

ANTITHROMBINS; FIBRINOGEN; HUMANS; PHOTINIA; PLANT EXTRACTS; PLATELET AGGREGATION; POLYPHENOLS; SEEDS; VITIS;

PHOTINIA; PHOTINIA MELANOCARPA; VITACEAE; VITIS VINIFERA;

EID: 84872069634     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4682     Document Type: Article

References (48)

1. Adams TE, Huntington JA,. 2006. Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol 26: 1738-1745.
2. Becker RC, Spencer FA,. 1998. Thrombin: structure, biochemistry, measurement, and status in clinical medicine. J Thromb Thrombolysis 5: 215-229.
3. Bijak M, Bobrowski M,. 2010. The importance of thrombin inhibitors in the antithrombotic pharmacotherapy. Prog Med 10: 819-825.
4. Bijak M, Bobrowski M, Borowiecka M, Podsedek A, Golanski J, Nowak P,. 2011. Anticoagulant effect of polyphenols-rich extracts from black chokeberry and grape seeds. Fitoterapia 82: 811-817.
5. Bode W,. 2006. Structure and interaction modes of thrombin. Blood Cells Mol Dis 36: 122-130.
6. Brass S,. 2001. Cardiovascular biology. Platelets and proteases. Nature 413: 26-27.
7. Carter WJ, Cama E, Huntington JA,. 2005. Crystal structure of thrombin bound to heparin. J Biol Chem 280: 2745-2749.
8. Connolly SJ, Ezekowitz MD, Yusuf S, et al,. 2009. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139-1151.
9. Cuccioloni M, Mozzicafreddo M, Sparapani L, et al,. 2009. Pomegranate fruit components modulate human thrombin. Fitoterapia 80: 301-305.
10. Dangles O, Dufour C, Manach C, Morand C, Remesy C,. 2001. Binding of flavonoids to plasma proteins. Methods Enzymol 335: 319-333.
11. Dery O, Corvera CU, Steinhoff M, Bunnett NW,. 1998. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274: 1429-1452.
12. + binding site of thrombin. J Biol Chem 270: 22089-22092.
13. Di Cera E,. 2003. Thrombin interactions. Chest 124: 11-17.
14. Di Cera E,. 2007. Thrombin as procoagulant and anticoagulant. J Thromb Haemost 5 (Suppl 1): 196-202.
15. Di Cera E,. 2008. Thrombin. Mol Aspects Med 29: 203-254.
16. Dohadwala MM, Vita JA,. 2009. Grapes and cardiovascular disease. J Nutr 139: 1788-1793.
17. Doolittle RF, Schubert D, Schwartz SA,. 1967. Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys 118: 456-467.
18. Eriksson BI, Smith H, Yasothan U, Kirkpatrick P,. 2008. Dabigatran etexilate. Nat Rev Drug Discov 7: 557-558.
19. European Medicines Agency. 2011. European Medicines Agency updates on safety of Pradaxa. http://www.ema.europa.eu/docs/en-GB/document-library/Press- release/2011/11/WC500117818.pdf
20. Ezekowitz MD, Reilly PA, Nehmiz G, et al,. 2007. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol 100: 1419-1426.
21. Hirano K, Kanaide H,. 2003. Role of protease-activated receptors in the vascular system. J Atheroscler Thromb 10: 211-225.
22. Kowalczyk E, Fijalkowski P, Kura M, et al,. 2005. The influence of anthocyanins from Aronia melanocarpa on selected parameters of oxidative stress and microelements contents in men with hypercholesterolemia. Pol Merkur Lekarski 19: 651-653.
23. Kulling S, Rawel H,. 2008. Chokeberry (Aronia melanocarpa)-a review on the characteristic components and potential health effect. Planta Med 74: 1625-1634.
24. Lane DA, Philippou H, Huntington JA,. 2005. Directing thrombin. Blood 106: 2605-2612.
25. Lapetina EG,. 1990. The signal transduction induced by thrombin in human platelets. FEBS Lett 268: 400-404.
26. Leifert WR, Abeywardena MY,. 2008. Cardioprotective actions of grape polyphenols. Nutr Res 28: 729-737.
27. Licari LG, Kovacic JP,. 2009. Thrombin physiology and pathophysiology. J Vet Emerg Crit Care (San Antonio) 19: 11-22.
28. Lottenberg R, Hall JA, Fenton JW, Jackson CM,. 1982. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins. Thromb Res 28: 313-332.
29. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L,. 2004. Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727-747.
30. Manach C, Williamson G, Morand C, Scalbert A, Remesy C,. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230-242.
31. Mosesson MW,. 2005. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3: 1894-1904.
32. Mozzicafreddo M, Cuccioloni M, Eleuteri AM, Fioretti E, Angeletti M,. 2006. Flavonoids inhibit the amidolytic activity of human thrombin. Biochimie 88: 1297-1306.
33. Naruszewicz M, Laniewska I, Millo B, Dluzniewski M,. 2007. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI). Atherosclerosis 194: 179-184.
34. Nesheim M,. 2003. Thrombin and fibrinolysis. Chest 124: 33-39.
35. Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J, Wachowicz B,. 2007. Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121: 163-174.
36. Olas B, Wachowicz B, Tomczak A, Erler J, Stochmal A, Oleszek W,. 2008a. Comparative anti-platelet and antioxidant properties of polyphenol-rich extracts from: berries of Aronia melanocarpa, seeds of grape and bark of Yucca schidigera in vitro. Platelets 19: 70-77.
37. Olas B, Wachowicz B, Nowak P, et al,. 2008b. Studies on antioxidant properties of polyphenol-rich extract from berries of Aronia melanocarpa in blood platelets. J Physiol Pharmacol 59: 823-835.
38. Ossovskaya VS, Bunnett NW,. 2004. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621.
39. Pawlaczyk I, Czerchawski L, Kuliczkowski W, et al,. 2011. Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L. Thromb Res 127: 328-340.
40. Ramachandran R, Hollenberg MD,. 2008. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 (Suppl 1): 263-282.
41. Saluk-Juszczak J, Olas B, Pawlaczyk I, Gancarz R, Wachowicz B,. 2007. Effects of the extract from Conyza canadensis on human blood platelet aggregation. Gen Physiol Biophys 26: 150-152.
42. Schmidlin F, Bunnett NW,. 2001. Protease-activated receptors: how proteases signal to cells. Curr Opin Pharmacol 1: 575-582.
43. Schwienhorst A,. 2006. Direct thrombin inhibitors-a survey of recent developments. Cell Mol Life Sci 63: 2773-2791.
44. Shrivastava S, McVey JH, Dorling A,. 2007. The interface between coagulation and immunity. Am J Transplant 7: 499-506.
45. Sonder SA, Fenton JW,. 1986. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities. Clin Chem 32: 934-937.
46. Vitseva O, Varghese S, Chakrabarti S, Folts JD, Freedman JE,. 2005. Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc Pharmacol 46: 445-451.
47. Walkowiak B, Kralisz U, Michalec L, et al,. 2000. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 99: 495-502.
48. Wolberg AS,. 2007. Thrombin generation and fibrin clot structure. Blood Rev 21: 131-142.